Sudden Cardiac Death Prediction in Non-ischemic Dilated Cardiomyopathy: a Multiparametric and Dynamic Approach.
Daniel J HammersleyBrian P HallidayPublished in: Current cardiology reports (2020)
Current international guidelines for primary prevention implantable defibrillator therapy do not result in improved longevity for many patients with non-ischemic cardiomyopathy and severe left ventricular dysfunction. More precise methods for identifying higher-risk patients that derive true prognostic benefit from this therapy are required. Dynamic and multi-parametric characterization of myocardial, electrical, serological and genetic substrate offers novel strategies for predicting major arrhythmic risk. Balancing the risk of non-sudden death offers an opportunity to personalize therapy and avoid unnecessary device implantation for those less likely to derive benefit.
Keyphrases
- left ventricular
- end stage renal disease
- heart failure
- chronic kidney disease
- newly diagnosed
- ejection fraction
- cardiac resynchronization therapy
- gene expression
- ischemia reperfusion injury
- acute myocardial infarction
- early onset
- bone marrow
- patient reported outcomes
- mesenchymal stem cells
- genome wide
- mitral valve
- atrial fibrillation
- drosophila melanogaster
- patient reported